tradingkey.logo

Revvity Inc

RVTY
View Detailed Chart
96.200USD
-0.060-0.06%
Close 12/19, 16:00ETQuotes delayed by 15 min
10.97BMarket Cap
48.35P/E TTM

Revvity Inc

96.200
-0.060-0.06%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.06%

5 Days

-4.27%

1 Month

+2.32%

6 Months

+1.27%

Year to Date

-13.81%

1 Year

-14.53%

View Detailed Chart

TradingKey Stock Score of Revvity Inc

Currency: USD Updated: 2025-12-19

Key Insights

Revvity Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 36/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 111.72.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Revvity Inc's Score

Industry at a Glance

Industry Ranking
36 / 208
Overall Ranking
112 / 4582
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 20 analysts
Buy
Current Rating
111.718
Target Price
+11.95%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Revvity Inc Highlights

StrengthsRisks
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 12.14%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.14%.
Fairly Valued
The company’s latest PE is 48.37, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 117.06M shares, decreasing 7.01% quarter-over-quarter.
Held by Ken Fisher
Star Investor Ken Fisher holds 15.56K shares of this stock.

Revvity Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Revvity Inc Info

Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Ticker SymbolRVTY
CompanyRevvity Inc
CEOSingh (Prahlad R)
Websitehttps://www.revvity.com/

FAQs

What is the current price of Revvity Inc (RVTY)?

The current price of Revvity Inc (RVTY) is 96.200.

What is the symbol of Revvity Inc?

The ticker symbol of Revvity Inc is RVTY.

What is the 52-week high of Revvity Inc?

The 52-week high of Revvity Inc is 128.285.

What is the 52-week low of Revvity Inc?

The 52-week low of Revvity Inc is 81.360.

What is the market capitalization of Revvity Inc?

The market capitalization of Revvity Inc is 10.97B.

What is the net income of Revvity Inc?

The net income of Revvity Inc is 270.38M.

Is Revvity Inc (RVTY) currently rated as Buy, Hold, or Sell?

According to analysts, Revvity Inc (RVTY) has an overall rating of Buy, with a price target of 111.718.

What is the Earnings Per Share (EPS TTM) of Revvity Inc (RVTY)?

The Earnings Per Share (EPS TTM) of Revvity Inc (RVTY) is 1.990.
KeyAI